Preview

Amur Medical Journal

Advanced search

Effects of Imunofan on Endogenous Intoxication Syndrome and Immunity in Patients with Reproductive System Tumors During Special Treatment.

https://doi.org/10.24412/2311-5068-2024-12-1-43

Abstract

Success in the treatment of malignant neoplasms is due to early diagnosis and an integrated approach to treatment. The identification of immunotherapy as a separate type of complex cancer therapy is beyond doubt. In order to increase the effectiveness of antitumor therapy, aggressive radiation and drug treatment regimens are being developed and applied. This leads to the development of immune disorders, allergic and infectious complications in patients. Side effects of special treatment, in turn, interfere with the optimal treatment of the main treatment, reduce its effectiveness and worsen the patient’s quality of life. The results of the study confirm the effect of Imunofan on immunity in patients with malignant neoplasms of the reproductive system. Immunomodulation, especially in conditions of intense intoxication, can play an important role in supporting the body’s defenses. This opens up new prospects for the development of complex treatment strategies that include Imunofan as an important component.

About the Authors

O. V. Lysenko
Amur State Medical Academy of the Ministry of Health of the Russian Federation
Russian Federation


M. V. Karpenko
Scientific and production enterprise «Bionox»
Russian Federation


Yu. V. Skabelkina
Amur State Medical Academy of the Ministry of Health of the Russian Federation
Russian Federation


E. S. Gribova
Amur Regional Oncology Dispensary
Russian Federation


G. V. Atamashkina
Amur Regional Oncology Dispensary
Russian Federation


E. M. Ustinov
Amur State Medical Academy of the Ministry of Health of the Russian Federation
Russian Federation


References

1. Gorbunova VA, SteninaMV, editors. Antitumor drug therapy: national guidelines. Moscow : GEOTAR Media, 2022. 708 p. (in Russ.).

2. Prokhach NE, Sorochan PP, Gromakova IA. Current experience and prospects for the use of immunomodulators in the complex therapy of cancer patients. International Medical Journal. 2006;4:86–93. (in Russ.).

3. Grinevich YuA. Immunotherapy in antitumor and anti-relapse treatment of cancer patients. Doctor. 2003;4:32–34. (in Russ.).

4. Khaitov RM, Pinegin BV. Basic principles of immunomodulating therapy. Allergy, asthma and clinical immunology. 2000;1:9–16. (in Russ.).

5. Nelson RP, Ballow M. Immynomodulation and immynotherapy: drugs, cytokines, cytokine receptors and antibodies. J. Allergy Clin. Immunol. 2003;111;Suppl:720–743.


Review

For citations:


Lysenko O.V., Karpenko M.V., Skabelkina Yu.V., Gribova E.S., Atamashkina G.V., Ustinov E.M. Effects of Imunofan on Endogenous Intoxication Syndrome and Immunity in Patients with Reproductive System Tumors During Special Treatment. Amur Medical Journal. 2024;12(1):44-52. (In Russ.) https://doi.org/10.24412/2311-5068-2024-12-1-43

Views: 4

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-5068 (Print)